Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in C. elegans Model of Parkinson’s Disease
Pawanrat Chalorak, Tanatcha Sanguanphun, Tanapol Limboonreung, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4843-4843
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Marine natural products
Anthony R. Carroll, Brent R. Copp, Rohan A. Davis, et al.
Natural Product Reports (2023) Vol. 40, Iss. 2, pp. 275-325
Closed Access | Times Cited: 185
Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent
Jing Wang, Li Zeng, Ying Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 48
The anti-aging mechanism of ginsenosides with medicine and food homology
Tiantian Tian, Chung-Nga Ko, Wenya Luo, et al.
Food & Function (2023) Vol. 14, Iss. 20, pp. 9123-9136
Closed Access | Times Cited: 24
Phytomedicine for neurodegenerative diseases: The road ahead
Dev Madhubala, Aparup Patra, Mojibur R. Khan, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2993-3019
Closed Access | Times Cited: 10
Potential therapeutic use of plant flavonoids in AD and PD
Sun Meng-zhen, Li Ju, Lanchun Zhang, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11440-e11440
Open Access | Times Cited: 31
Exploring Caenorhabditis elegans as Parkinson’s Disease Model: Neurotoxins and Genetic Implications
Larissa Pereira Dantas da Silva, Érika da Cruz Guedes, Isabel Cristina Oliveira Fernandes, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 6
D-chiro-inositol increases antioxidant capacity and longevity of Caenorhabditis elegans via activating Nrf-2/SKN-1 and FOXO/DAF-16
Lin Shi, Xin-Tian Yu, Han Li, et al.
Experimental Gerontology (2023) Vol. 175, pp. 112145-112145
Open Access | Times Cited: 14
Snake venom nerve growth factor-inspired designing of novel peptide therapeutics for the prevention of paraquat-induced apoptosis, neurodegeneration, and alteration of metabolic pathway genes in the rat pheochromocytoma PC-12 cell
Dev Madhubala, Aparup Patra, Taufikul Islam, et al.
Free Radical Biology and Medicine (2023) Vol. 197, pp. 23-45
Closed Access | Times Cited: 13
27-Hydroxymangiferolic Acid Extends Lifespan and Improves Neurodegeneration in Caenorhabditis elegans by Activating Nuclear Receptors
Xiaoyan Gao, Jing Yu, Li Yin, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1010-1010
Open Access
Marine Pharmacology in 2019–2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action
Alejandro M. S. Mayer, Veronica A. Mayer, Michelle Swanson‐Mungerson, et al.
Marine Drugs (2024) Vol. 22, Iss. 7, pp. 309-309
Open Access | Times Cited: 4
Ginsenosides Rg1, Rb1 and rare ginsenosides: promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
Mingchun Jiang, Jiaxin Chi, Yifan Qiao, et al.
Pharmacological Research (2025) Vol. 212, pp. 107578-107578
Open Access
Snake Venom-Inspired Novel Peptides Protect Caenorhabditis elegans against Paraquat-Induced Parkinson’s Pathology
Dev Madhubala, Rosy Mahato, Kangkon Saikia, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities
Angie K. Torres, Rodrigo G. Mira, Cristina Pinto, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
Hederagenin inhibits mitochondrial damage in Parkinson’s disease via mitophagy induction
Xiaoqian Li, Mengling Hu, Xiaogang Zhou, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 3
Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
Xiaotong Wang, Nianxin Kang, Ying Liu, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5364-5364
Open Access | Times Cited: 3
Citrus Flavonoid Hesperetin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Reduces Their Cytotoxicity: In Vitro and In Vivo Studies
Wenqian Wang, Lili Qu, Zhan Cui, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 43, pp. 16174-16183
Closed Access | Times Cited: 8
Using Caenorhabditis elegans to Model Therapeutic Interventions of Neurodegenerative Diseases Targeting Microbe-Host Interactions
Chenyin Wang, Chaogu Zheng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
C. elegans : a prominent platform for modeling and drug screening in neurological disorders
Stefano Romussi, Sebastián Giunti, Natalia Andersen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 565-585
Closed Access | Times Cited: 2
Nicotine-mediated therapy for Parkinson’s disease in transgenic Caenorhabditis elegans model
Inam Ullah, Longhe Zhao, Shahab Uddin, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson’s Disease Models of Caenorhabditis elegans
Li He, Jingjing Du, Junjie Zhou, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 9
Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease
Yingying Ding, Benson O. A. Botchway, Yong Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 12, pp. 5537-5550
Closed Access | Times Cited: 5
Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson’s Disease
Serena Silvestro, Ivana Raffaele, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16233-16233
Open Access | Times Cited: 5
Snake venom-inspired novel peptides protectCaenorhabditis elegansagainst paraquat-induced Parkinson’s pathology
Dev Madhubala, Kangkon Saikia, Aparup Patra, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
1-Mesityl-3-(3-Sulfonatopropyl) Imidazolium Protects Against Oxidative Stress and Delays Proteotoxicity in C. elegans
Natalia Andersen, Tania Veuthey, María Gabriela Blanco, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Application of Caenorhabditis elegans in the evaluation of food nutrition: A review
Quancen Li, Meifang Xiao, Na Li, et al.
eFood (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top